Examiners Amendment

TERAGENIX

Teragenix Corporation

Examiners Amendment

UNITED STATES PATENT AND TRADEMARK OFFICE

UNITED STATES PATENT AND TRADEMARK OFFICE

 

    SERIAL NO: 76/373449

 

    APPLICANT:         Teragenix Corporation

 

      

 

       

 

    CORRESPONDENT ADDRESS:

TAMARA CARMICHAEL, P.A.

BROAD AND CASSEL

201 SOUTH BISCAYNE BOULEVARD, SUITE 3000

MIAMI, FLORIDA 33131

 

RETURN ADDRESS: 

Commissioner for Trademarks

2900 Crystal Drive

Arlington, VA 22202-3513

ecom114@uspto.gov

 

 

If no fees are enclosed, the address should include the words "Box Responses - No Fee."

    MARK:          TERAGENIX

 

 

 

    CORRESPONDENT’S REFERENCE/DOCKET NO:   29220.0002

 

    CORRESPONDENT EMAIL ADDRESS: 

 

Please provide in all correspondence:

 

1.  Filing date, serial number, mark and

     applicant's name.

2.  Date of this Office Action.

3.  Examining Attorney's name and

     Law Office number.

4.  Your telephone number and email address.

 

 

Serial Number  76/373449

 

 

EXAMINER’S AMENDMENT

 

In accordance with the authorization granted by David Adams on March 12, 2003, the application has been AMENDED as indicated below.  Please note that if the identification of goods or services has been amended below, any future amendments must be in accordance with 37 C.F.R. 2.71(a); TMEP section 1402.07(e).  No response is necessary unless there is an objection to the amendment.  If there is an objection to the amendment, the applicant should notify the examining attorney immediately.

 

Amend Class 40 to: manufacturing services to the order and specifications of others of the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries, namely, the manufacturing of quality control products such as panels and medical devices such as controls, standard and calibrators.

 

Amend Class 42 to: Clinical trial management services and biological specimen collection services for the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries; Clinical trial management services including the design of clinical trials, the collection, handling, and storage of human biological specimens, the collection, discovery, analysis and presentation of clinical trial data for use in medical research, in-vitro diagnostic product development and pharmaceutical product development; Clinical trial management services including assistance with regulatory submissions, laboratory testing services and logistics management; Biological specimen collection services including the prospective collection of biological specimens, the design of collection protocols, the submission of regulatory filings, the transport of biological specimens, the collection of characterization data related to biological specimens and the accumulation of a database of characterization data related to biological specimens.

 

 

/Raul Cordova/

Trademark Examing Attorney

Law Office 114 (703)308-9114 x136

www.ecom114@uspto.gov

Right fax no. (703)746-8114

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed